Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2025-12-26 @ 4:06 AM
Study NCT ID:
NCT04012918
Status:
UNKNOWN
Last Update Posted:
2019-07-09
First Post:
2019-05-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Capecitabine in Combination With Aromatase Inhibitor Versus Aromatase Inhibitors, in Hormonal Receptor Positive Recurrent or Metastatic Breast Cancer Patients, Randomized Controlled Study
Sponsor:
Ain Shams University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-30
Start Date Type:
ACTUAL
Primary Completion Date:
2020-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-02
Completion Date Type:
ESTIMATED
First Submit Date:
2019-05-16
First Submit QC Date:
None
Study First Post Date:
2019-07-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-06
Last Update Post Date:
2019-07-09
Last Update Post Date Type:
ACTUAL